Harvest Fund Management Co., Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Harvest Fund Management Co., Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$51
-75.1%
574
-76.2%
0.01%
-78.0%
Q2 2023$205
+83.0%
2,411
+78.7%
0.04%
+64.0%
Q1 2023$112
+202.7%
1,349
+185.8%
0.02%
+150.0%
Q4 2022$37
-99.9%
4720.0%0.01%0.0%
Q3 2022$35,000
+191.7%
472
+84.4%
0.01%
+900.0%
Q4 2019$12,000
-92.2%
256
-78.9%
0.00%
-95.0%
Q3 2019$153,000
+264.3%
1,213
+247.6%
0.02%
+300.0%
Q2 2019$42,000
-85.7%
349
-88.1%
0.01%
-91.8%
Q4 2018$293,000
-48.6%
2,929
-41.1%
0.06%
-37.8%
Q3 2018$570,0004,9750.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders